| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 25.996 | 90.601 | 94.695 | 123.744 | 119.960 | 144.254 | 196.200 |
| Total Income - EUR | 0 | 0 | 0 | 26.118 | 90.725 | 94.729 | 123.748 | 120.010 | 144.416 | 196.287 |
| Total Expenses - EUR | 0 | 0 | 0 | 28.529 | 61.397 | 61.294 | 61.698 | 68.508 | 111.286 | 133.875 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | -2.412 | 29.328 | 33.436 | 62.049 | 51.502 | 33.130 | 62.412 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | -2.671 | 28.422 | 32.539 | 60.837 | 50.446 | 31.861 | 58.030 |
| Employees | 0 | 0 | 0 | 2 | 3 | 3 | 3 | 3 | 2 | 3 |
Check the financial reports for the company - Amidalima Protep S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 53.028 | 45.218 | 38.274 | 30.681 | 24.011 | 113.864 | 94.418 |
| Current Assets | 144 | 143 | 141 | 13.065 | 26.725 | 22.708 | 35.487 | 32.581 | 26.603 | 54.535 |
| Inventories | 135 | 133 | 131 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 10.974 | 13.978 | 13.390 | 14.999 | 18.425 | 20.116 | 51.874 |
| Cash | 10 | 10 | 9 | 2.091 | 12.747 | 9.318 | 20.488 | 14.156 | 6.487 | 2.661 |
| Shareholders Funds | -13 | -13 | -13 | -2.684 | 25.790 | 41.301 | 60.897 | 50.528 | 67.512 | 97.632 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 158 | 156 | 153 | 68.776 | 46.153 | 19.681 | 5.271 | 6.064 | 72.954 | 51.320 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2562 - 2562" | |||||||||
| CAEN Financial Year |
2562
|
|||||||||
Comments - Amidalima Protep S.r.l.